JP2010526819A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526819A5 JP2010526819A5 JP2010507607A JP2010507607A JP2010526819A5 JP 2010526819 A5 JP2010526819 A5 JP 2010526819A5 JP 2010507607 A JP2010507607 A JP 2010507607A JP 2010507607 A JP2010507607 A JP 2010507607A JP 2010526819 A5 JP2010526819 A5 JP 2010526819A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- group
- hydrogen
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C=C(*)C=C1)C=C1c1nccnc1N1CCN(Cc2c(*)[n](*)nc2*)CC1 Chemical compound CC(C=C(*)C=C1)C=C1c1nccnc1N1CCN(Cc2c(*)[n](*)nc2*)CC1 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91743107P | 2007-05-11 | 2007-05-11 | |
| US60/917,431 | 2007-05-11 | ||
| US97420907P | 2007-09-21 | 2007-09-21 | |
| US60/974,209 | 2007-09-21 | ||
| PCT/US2008/062834 WO2008141020A1 (en) | 2007-05-11 | 2008-05-07 | 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010526819A JP2010526819A (ja) | 2010-08-05 |
| JP2010526819A5 true JP2010526819A5 (OSRAM) | 2011-05-26 |
| JP5210375B2 JP5210375B2 (ja) | 2013-06-12 |
Family
ID=39629131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010507607A Expired - Fee Related JP5210375B2 (ja) | 2007-05-11 | 2008-05-07 | ５−ｈｔ７受容体拮抗薬としての２−［４−（ピラゾール−４−イルアルキル）ピペラジン−１−イル］−３−フェニルピラジンおよびピリジンならびに３−［４−（ピラゾール−４−イルアルキル）ピペラジン−１−イル］−２−フェニルピリジン |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8202873B2 (OSRAM) |
| EP (1) | EP2155717B1 (OSRAM) |
| JP (1) | JP5210375B2 (OSRAM) |
| KR (1) | KR101119294B1 (OSRAM) |
| CN (1) | CN101861312B (OSRAM) |
| AU (1) | AU2008251584B2 (OSRAM) |
| BR (1) | BRPI0811446A2 (OSRAM) |
| CA (1) | CA2684563C (OSRAM) |
| CY (1) | CY1113457T1 (OSRAM) |
| DK (1) | DK2155717T3 (OSRAM) |
| EA (1) | EA016529B1 (OSRAM) |
| ES (1) | ES2395872T3 (OSRAM) |
| HR (1) | HRP20120919T1 (OSRAM) |
| MX (1) | MX2009012126A (OSRAM) |
| PL (1) | PL2155717T3 (OSRAM) |
| PT (1) | PT2155717E (OSRAM) |
| WO (1) | WO2008141020A1 (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2474581C2 (ru) * | 2007-12-26 | 2013-02-10 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Способ получения замещенных гетероциклом производных пиридина |
| WO2011012620A2 (en) * | 2009-07-31 | 2011-02-03 | Syngenta Participations Ag | Processes for the alkylation of pyrazoles |
| EP2502909A4 (en) | 2009-11-18 | 2013-04-03 | Takeda Pharmaceutical | aminopyridine derivative |
| EP2566333A4 (en) | 2010-05-07 | 2014-04-02 | Univ Leland Stanford Junior | IDENTIFICATION OF STABILIZERS OF MULTIMEDER PROTEINS |
| JP5869570B2 (ja) * | 2010-08-10 | 2016-02-24 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | ３−ハロアルキルピラゾールの調製方法 |
| US10351535B2 (en) * | 2013-12-20 | 2019-07-16 | Esteve Pharmaceuticals, S.A. | Piperazine derivatives having multimodal activity against pain |
| EP3179857B1 (en) | 2014-08-14 | 2021-09-08 | Mamoun M. Alhamadsheh | Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life |
| CN104592199A (zh) * | 2015-01-22 | 2015-05-06 | 杭州利巴医药科技有限公司 | 一种取代的1-(2-吡啶基)-吡唑-4-基乙酸及其衍生物和制备方法 |
| CN104945325B (zh) * | 2015-06-19 | 2017-04-05 | 浙江永太科技股份有限公司 | 一种吡唑甲酸衍生物的制备方法 |
| NZ797281A (en) | 2017-02-17 | 2025-10-31 | Eidos Therapeutics Inc | Processes for preparing ag-10, its intermediates, and salts thereof |
| KR20200135996A (ko) | 2018-03-23 | 2020-12-04 | 에이도스 테라퓨틱스, 인코포레이티드 | Ag10을 사용하여 ttr 아밀로이드증을 치료하는 방법 |
| EP4647068A2 (en) | 2018-08-17 | 2025-11-12 | Eidos Therapeutics, Inc. | Formulations of ag10 |
| KR102514860B1 (ko) * | 2020-12-01 | 2023-03-29 | 한국과학기술연구원 | 5-ht7 세로토닌 수용체 활성 저해용 바이페닐 피롤리딘 및 바이페닐 다이하이드로이미다졸 유도체 및 이를 유효성분으로 포함하는 약학 조성물 |
| CN115974785A (zh) * | 2022-12-09 | 2023-04-18 | 南京先进生物材料与过程装备研究院有限公司 | 一种3,5-二取代吡唑类化合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2079323B1 (es) * | 1994-06-21 | 1996-10-16 | Vita Invest Sa | Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes. |
| EP1676844A1 (en) * | 2004-12-28 | 2006-07-05 | Laboratorios Del Dr. Esteve, S.A. | 5-HT7 receptor antagonists |
| MXPA05008137A (es) * | 2003-01-31 | 2005-09-30 | Pfizer Prod Inc | Antagonistas y agonistas de 5ht7. |
| US20050080076A1 (en) * | 2003-10-08 | 2005-04-14 | Xanodyne Pharmacal, Inc. | N-desmethyl levomepromazine |
-
2008
- 2008-05-07 PT PT87477485T patent/PT2155717E/pt unknown
- 2008-05-07 ES ES08747748T patent/ES2395872T3/es active Active
- 2008-05-07 HR HRP20120919AT patent/HRP20120919T1/hr unknown
- 2008-05-07 JP JP2010507607A patent/JP5210375B2/ja not_active Expired - Fee Related
- 2008-05-07 DK DK08747748.5T patent/DK2155717T3/da active
- 2008-05-07 AU AU2008251584A patent/AU2008251584B2/en not_active Ceased
- 2008-05-07 CN CN200880015741.XA patent/CN101861312B/zh not_active Expired - Fee Related
- 2008-05-07 EP EP08747748A patent/EP2155717B1/en not_active Not-in-force
- 2008-05-07 WO PCT/US2008/062834 patent/WO2008141020A1/en not_active Ceased
- 2008-05-07 EA EA200971052A patent/EA016529B1/ru not_active IP Right Cessation
- 2008-05-07 US US12/597,255 patent/US8202873B2/en not_active Expired - Fee Related
- 2008-05-07 CA CA2684563A patent/CA2684563C/en not_active Expired - Fee Related
- 2008-05-07 BR BRPI0811446-3A2A patent/BRPI0811446A2/pt not_active Application Discontinuation
- 2008-05-07 MX MX2009012126A patent/MX2009012126A/es active IP Right Grant
- 2008-05-07 KR KR1020097022901A patent/KR101119294B1/ko not_active Expired - Fee Related
- 2008-05-07 PL PL08747748T patent/PL2155717T3/pl unknown
-
2012
- 2012-12-13 CY CY20121101219T patent/CY1113457T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010526819A5 (OSRAM) | ||
| EP1857457A3 (en) | Benzimidazole derivative and its use as AII receptor antagonist | |
| JP2014530900A5 (OSRAM) | ||
| CA2534672A1 (en) | Cyclic amine bace-1 inhibitors having a heterocyclic substituent | |
| HRP20120919T1 (hr) | 2-[4-(pirazol-4-ilalkil)piperazin-1-il]-3-fenilpirazini i -piridini i 3-[4-(pirazol-4-ilalkil)piperazin-1-il]-2-fenilpiridini kao antagonisti receptora 5-ht7 | |
| JP2006524660A5 (OSRAM) | ||
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| JP2019510787A5 (OSRAM) | ||
| RU2017127135A (ru) | Терапевтическое средство против рака желчных протоков | |
| RU2009117705A (ru) | Производные 2-аминокарбонилпиридина | |
| NO20064133L (no) | 5,6-dialkyl-7-amino-triazolpyrimidiner, fremgangsmate for fremstilling- av dem, deres anvendelse for a bekjempe skadelig sopp, og midler som inneholder disse forbindelsene | |
| JP2014037426A5 (OSRAM) | ||
| JP2007519754A5 (OSRAM) | ||
| JP2017537949A5 (OSRAM) | ||
| NO20084845L (no) | 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig | |
| JP2013532652A5 (OSRAM) | ||
| RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JP2012530765A5 (OSRAM) | ||
| CA2647036A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
| JP2018513190A5 (OSRAM) | ||
| RU2011140869A (ru) | Пиперазиновое соединение, ингибирующее простагландин-d-синтазу | |
| CN115315423A (zh) | 取代芳基类化合物 | |
| RU2489433C2 (ru) | Производное циклобутилпурина, агент, активирующий ангиогенез, агент, активирующий образование просвета, агент, активирующий рост нейронов, и лекарственное средство | |
| EP3250036A1 (en) | Small molecule inhibitors of fibrosis |